SNAI1 and breast cancer: AXL was shown to control the expression of the transcription factors SNAI1/2 and TWIST1/2 in pancreatic cancer [89] and, in breast cancer, to activate the AKT/GSK3β/β-Catenin cascade that induces expression of ZEB1 and other EMT-related genes [90].